top of page
  • White Facebook Icon
  • White Twitter Icon
Search

Divestment

Updated: Jan 12, 2023

Scope law advises an institutional investor in its divestment in connection with Biognosys AG’s strategic partnership with Bruker Corporation.


Biognosys AG and Bruker Corporation (Nasdaq: BRKR) announced a strategic partnership, in which Bruker has made a majority-ownership investment in the ETH spin-off Biognosys. Financial details were not disclosed. Scope law’s client has, together with other investors, sold its shares to Bruker in a secondary transaction, and Bruker will make new primary investments in Biognosys.


 
 
 

Recent Posts

See All
M&A Transaction

Scope Law advises Jung von Matt IMPACT AG , Zurich, on its strategic participation in the Generation Media AG , Zurich. Jung von Matt...

 
 
 
Financing Round

Scope Law advises ETFbook , Zurich, in its EUR 4 million Series A financing round, led by BlackFin Capital Partners BlackFin Capital...

 
 
 
Financinground

Scope Law advises qCella AG , Zurich, a spin-off of ETH Zurich in its CHF 1.3 million pre-seed financing round. Participating investors...

 
 
 

Comments

bottom of page